Assembly Biosciences Files 8-K
Ticker: ASMB · Form: 8-K · Filed: Dec 26, 2024 · CIK: 1426800
| Field | Detail |
|---|---|
| Company | Assembly Biosciences, INC. (ASMB) |
| Form Type | 8-K |
| Filed Date | Dec 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financial-statements
TL;DR
ASMB filed an 8-K on 12/26/24. Standard corporate update.
AI Summary
Assembly Biosciences, Inc. filed an 8-K on December 26, 2024, reporting other events and financial statements. The company, formerly known as Ventrus Biosciences Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates routine corporate reporting, including financial statements and other events, which provides transparency to investors about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not appear to contain any significant new risks or material adverse information.
Key Numbers
- 001-35005 — SEC File Number (Identifies the company's filing with the SEC.)
- 20-8729264 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Assembly Biosciences, Inc. (company) — Registrant
- Ventrus Biosciences Inc. (company) — Former Company Name
- Delaware (jurisdiction) — State of Incorporation
- 20241226 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing for Assembly Biosciences, Inc.?
The primary purpose of this 8-K filing is to report "Other Events" and "Financial Statements and Exhibits" as of December 26, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on December 26, 2024.
What was Assembly Biosciences, Inc. formerly known as?
Assembly Biosciences, Inc. was formerly known as Ventrus Biosciences Inc.
In which state is Assembly Biosciences, Inc. incorporated?
Assembly Biosciences, Inc. is incorporated in Delaware.
What is the business address of Assembly Biosciences, Inc.?
The business address of Assembly Biosciences, Inc. is Two Tower Place, 7th Floor, South San Francisco, California 94080.
Filing Stats: 448 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2024-12-26 08:25:41
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 ASMB The Nasdaq Global Select Marke
Filing Documents
- asmb-20241226.htm (8-K) — 46KB
- asmb-ex99_1.htm (EX-99.1) — 25KB
- 0000950170-24-139962.txt ( ) — 196KB
- asmb-20241226.xsd (EX-101.SCH) — 31KB
- asmb-20241226_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On December 26, 2024, Assembly Biosciences, Inc. (the "Company") issued a press release announcing interim results from its ongoing Phase 1b clinical study evaluating its investigational next-generation capsid assembly modulator candidate ABI-4334 in participants with chronic hepatitis B virus infection. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press Release dated December 26, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Assembly Biosciences, Inc. Date: December 26, 2024 By: /s/ John O. Gunderson John O. Gunderson VP, General Counsel and Corporate Secretary 2